obesity drug news today glp-1 september 22 2025 How Supply and Demand for Weight Loss Drugs is Playing Out in 2026 GLP-1 Agonists Market Report 2025-2033,
Description
What are the benefits of GLP-1 drugs
S., Dehbi, H
This systematic review and meta-analysis provide updated evidence on the efficacy and safety of SGLT2i and GLP-1RAs on KT recipients
Nat Med 2020;26(4):485497
Throughout the GLP-1 shortage period, 503B facilities played a crucial role in supplying healthcare systems and clinics with compounded versions that met current Good Manufacturing Practice (cGMP) expectations
2024 Sales (USD): $13.42 billion Why it sold so well: Gilead Sciences flagship HIV treatment, Biktarvy, had exceptional growth in 2024, with global sales increasing 13% year-over-year to $13.4 billion
